A Comparative Study Between Laryseal Pro Supra Glottic Device (SGD) With Proseal Laryngeal Mask Airway
Launched by KASR EL AINI HOSPITAL · Jun 5, 2023
Trial Information
Current as of May 18, 2025
Completed
Keywords
ClinConnect Summary
This a randomized control trial is designed to include (120) patients ASA physical status I ,II patients ranging from(18) to(60)years old scheduled for ophthalmic surgery
Patients meeting the inclusion criteria will be randomly assigned to receive either:
Group A: Laryseal pro supra glottic device (SGD) (n=60) Group B: Laryngeal Mask Airway- Proseal™ (n=60) Anesthesia management
Preoperative procedures:
After being accepted into the study, participants age, gender, weight, medications and any other co morbidities will be collected. patients will be allowed to fast for 6-8 h before surge...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Both males and females
- • Age 18-60 years
- • GANZOURI airway scores less than 4
- • Patients undergoing ophthalmic surgeries not exceeding two hours under general anesthesia (cataract surgery,glaucoma surgery, corneal transplant, strabismus surgery
- Exclusion Criteria:
- • Patients have risks of gastric aspiration (patients known to have gastro esophageal reflux disease (GERD), hiatus hernia or previous upper gastrointestinal tract surgery)
- • patients have respiratory or pharyngeal pathology
- • morbidly obese patients with body mass index \>40 kg/m3
About Kasr El Aini Hospital
Kasr El Aini Hospital, a prestigious medical institution affiliated with Cairo University, is dedicated to advancing healthcare through innovative clinical research. With a commitment to excellence, the hospital serves as a leading sponsor of clinical trials, leveraging its state-of-the-art facilities and a multidisciplinary team of healthcare professionals. The institution focuses on a diverse range of therapeutic areas, aiming to improve patient outcomes and contribute to the global medical community. By fostering collaboration and adhering to the highest ethical standards, Kasr El Aini Hospital plays a pivotal role in the development of new treatments and therapies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Trial Officials
Maha Ismael, professor
Study Director
Anesthesia department , Cairo university
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported